Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2004Cancer

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMichael CrumpUniversity Health NetworkTBTara BaetzUniversity of British ColumbiaSCStephen CoubanDalhousie University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Crump et al. (2004) studied this question.

synapsesocial.com/papers/6a0ef55d53f874f2b222ffdahttps://doi.org/10.1002/cncr.20587
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study2000 · 2,313 citations
  2. 2A Predictive Model for Aggressive Non-Hodgkin's Lymphoma1993 · 5,013 citations
  3. 3Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.1995 · 105 citations
  4. 4A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]1994 · 6,335 citations
  5. 5Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer1999 · 474 citations